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Abstract
Covalent modification of DNA distinguishes cellular identities and is crucial for regulating the pluripotency and
differentiation of embryonic stem (ES) cells. The recent demonstration that 5-methylcytosine (5-mC) may be further
modified to 5-hydroxymethylcytosine (5-hmC) in ES cells has revealed a novel regulatory paradigm to modulate the
epigenetic landscape of pluripotency. To understand the role of 5-hmC in the epigenomic landscape of pluripotent cells,
here we profile the genome-wide 5-hmC distribution and correlate it with the genomic profiles of 11 diverse histone
modifications and six transcription factors in human ES cells. By integrating genomic 5-hmC signals with maps of histone
enrichment, we link particular pluripotency-associated chromatin contexts with 5-hmC. Intriguingly, through additional
correlations with defined chromatin signatures at promoter and enhancer subtypes, we show distinct enrichment of 5-hmC
at enhancers marked with H3K4me1 and H3K27ac. These results suggest potential role(s) for 5-hmC in the regulation of
specific promoters and enhancers. In addition, our results provide a detailed epigenomic map of 5-hmC from which to
pursue future functional studies on the diverse regulatory roles associated with 5-hmC.
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Introduction
The potency and fate of a cell can be influenced strongly by the
covalent modification of cytosine methylation at carbon five. This
critical epigenetic mark influences cellular potency and differentia-
tion by modulating DNA-protein interactions, which direct
epigenomic states and transcriptional processes, allowing otherwise
common genomes to be expressed as distinct cell types. DNA-
methylation-mediated epigenomic processes include dosage com-
pensation, control over aberrant retrotransposon expression, and
regulation of centromeric and telomeric heterochromatin [1]. The
importance of such processes is exemplified by the essential
requirement for DNA methyltransferases (DNMT1, DNMT3A,
and DNMT3B) in embryonic and early mammalian development
[2,3].
Coincident with critical roles for DNA methyltransferases in the
regulation of pluripotency, Fe(II)/a-ketoglutarate-dependent hy-
droxylation of 5-mC to 5-hydroxymethylcytosine (5-hmC) by Ten-
eleven translocation (Tet) family proteins also contributes to the
maintenance of pluripotency [4–6]. Discovery of this new
epigenetic modification raises the possibility that 5-hmC could
alter chromatin structure and thereby contribute to gene
regulation. Recent functional studies have shown that Tet
proteins, particularly Tet1 and Tet2, are required for ES cell
self-renewal and maintenance. However, despite the emergence of
these important roles for Tet family proteins, and therefore 5-
hmC-associated regulation in ES cells, the genomic- and
chromatin-associated contexts of 5-hmC have gone unexplored
in human embryonic stem cells.
Although there are detailed chromatin state maps of histone
modifications in human embryonic stem cells, much less is known
about the distinction between 5-hmC and 5-mC localization, largely
because of the inability of bisulfite sequencing to resolve the two
marks [7,8]. Recent studies indicate distinct differences in the
presence of stable 5-hmC and Tet1 in mouse ES cells, where strong
promoter-proximal Tet1 binding is inversely correlated with the
presence of both 5-mC and 5-hmC [9–13], providing putative
support for a Tet1-associated demethylation mechanism in the
maintenance of unmethylated active promoters. Interestingly, these
studies indicate that while Tet1 binding sites are highly enriched at
transcription start sites (TSSs) in mouse ES cells, a significant fraction
of detectable 5-hmC lies within gene bodies and other regulatory
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regions, which is also consistent with our previous study mapping 5-
hmC genome-wide in mouse cerebellum [14]. Furthermore, at
regions bound by both Polycomb (PRC2) and Tet1, the presence of
5-hmC is associated with a repressive state, indicating diverse
regulatory roles for 5-hmC that depend at least in part on its
chromatin context. Whether localization of 5-hmCwith other distinct
chromatin signatures results in diverse regulatory mechanisms
remains to be explored.
To unravel the biology of 5-hmC, we recently developed a
selective chemical labeling method for 5-hmC by using T4
bacteriophage ß-glucosyltransferase to transfer an engineered
glucose moiety containing an azide group onto the hydroxyl
group of 5-hmC, which in turn can chemically incorporate a
biotin group for detection, affinity enrichment, and sequencing.
Here, to understand the role of 5-hmC in the epigenomic
landscape of pluripotent cells, we profiled the genome-wide 5-
hmC distribution and correlated it with the genomic profiles of 11
diverse histone modifications and six transcription factors in
human ES cells. By integrating genomic 5-hmC signals with maps
of histone enrichment, we link particular pluripotency-associated
chromatin contexts with 5-hmC. Intriguingly, through additional
correlations with defined chromatin signatures at promoter and
enhancer subtypes, we found distinct enrichment of 5-hmC at
enhancers marked with H3K4me1 and H3K27ac. These results
suggest potential role(s) for 5-hmC in the regulation of specific
promoters and enhancers. In addition, our results provide a
detailed epigenomic map of 5-hmC from which to pursue future
functional studies on the diverse regulatory roles associated with 5-
hmC.
Results
Exclusion of 5-hmC from metaphase pericentromeric
heterochromatin
To assess the distribution and general chromatin context of 5-
hmC in human embryonic stem (ES) cells, we first evaluated the
cytogenetic localization of both 5-mC and 5-hmC by immunos-
taining metaphase chromosomes of human ES cells (Figure S1).
Both 5-mC and 5-hmC were clearly present along the chromo-
somal arms (Figure 1A–1D); however, 5-mC displayed a distinctly
strong signal at centromeric heterochromatin regions on all
metaphase spreads examined (Figure 1B, n.5). Strikingly, at
these same regions, 5-hmC appears completely depleted from 5-
Figure 1. 5-hmC- and 5-mC-specific immunostaining of metaphase chromosomes from human ES cells. Metaphase chromosomes from
human embryonic stem cells were immunostained with antibodies specific to 5-hmC and 5-mC. A–D, Both 5-hmC and 5-mC could be observed along
the chromosome arms. Strong 5-mC signal (yellow open arrow) but distinct exclusion of 5-hmC (white open arrow) from the heterochromatin of
pericentromeres and the Y chromosome was observed. 5-hmC is enriched in some regions of multiple chromosomes (solid arrow). E–H,
Representative images showing 5-hmC is strongly depleted from 5-mC-enriched pericentromeric region of chromosome 1 as indicated by arrow.
doi:10.1371/journal.pgen.1002154.g001
Author Summary
Recent studies revealed the oxygenase-catalyzed produc-
tion of 5-hydroxymethylcytosine (5-hmC) as a modification
to mammalian DNA. 5-hmC is known to play important
roles in self-renewal and cell lineage specification in
embryonic stem (ES) cells, suggesting a potential role for
5-hmC–mediated epigenetic regulation in modulating the
pluripotency of ES cells. To unveil this new regulatory
paradigm in human ES cells, here we use a 5-hmC–specific
chemical labeling approach to capture 5-hmC and profile
its genome-wide distribution in human ES cells. We show
that 5-hmC is an important epigenetic modification
associated with the pluripotent state that could play
role(s) in a subset of promoters and enhancers with
defined chromatin signatures in ES cells.
5-hmC in Human ES Cells
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mC-enriched pericentromeric regions (Figure 1A, 1E–1H). Given
both the defined epigenetic architecture and distinct sequence
content of relatively stable centromeric heterochromatic regions,
these results may suggest an association of 5-hmC with more
epigenetically dynamic loci, such as those throughout chromosome
arms, and perhaps exclusion from more epigenetically stable
heterochromatin, such as that present in metaphase centromeres.
Genomic features associated with 5-hmC in human
embryonic stem cells
To further evaluate the epigenomic context of 5-hmC, we first
established a genome-wide map of 5-hmC in human H1 ES cells by
selectively enriching 5-hmC-containing fragments of DNA and
subjecting them to high-throughput sequencing. We used a previously
established approach to transfer a chemically modified glucose moiety,
6-N3-glucose, onto the hydroxyl group of 5-hmC, which in turns
allows cycloaddition of biotin for affinity enrichment and deep
sequencing. We prepared and sequenced libraries from 5-hmC-
enriched as well as unenriched DNA from the same preparation and
sequenced to a depth of.10 million unique, non-duplicate reads per
condition. Analyses of chromosome-wide 5-hmC densities showed
that, while unenriched input genomic reads were distributed amongst
chromosomes close to randomly, as expected by chance, 5-hmC
exhibited enrichment or depletion on specific chromosomes
(Figure 2A).
To further localize regions of 5-hmC enrichment, we identified 5-
hmC peaks genome-wide. In total, we identified 82,221 regions as
significantly enriched for 5-hmC (p-value threshold of 1e-8, Table
S1). Association of 5-hmC-enriched regions with annotated
genomic features indicated significant overrepresentation of 5-
hmC within genes and depletion at intergenic regions (Figure 2B),
consistent with what has been observed previously in both mouse
cerebellum and mouse ES cells [9,11–14]. Within genes, 5-hmC
peaks were particularly enriched in exons (Figure 2B, 6.14-fold over
expected based on the genomic coverage of these regions), whereas
we saw much lower frequency within intronic regions (Figure 2B,
1.33-fold over expected), which is likely a result of the increased GC
content within exons relative to introns. 5-hmC peaks were also
significantly enriched within intragenic CpG islands (CGIs) (17.6-
fold over expected) and are more frequent than expected by chance
Figure 2. Summary of genome-wide distribution of 5-hmC in human H1 ES cells. A. Chromosome-wide distributions of 5-hmC-enriched
and -unenriched input genomic DNA reads (reads/million), compared to the distribution expected by chance if reads were randomly distributed
amongst chromosomes (106/hg18 length X chromosome length, with expected values divided by 2 for chromosome X). B. Association between
82,221 5-hmC enriched regions (p-value threshold of 1e-8) and annotated genomic features (obtained through UCSC Tables, NCBI36/hg18 and [15]).
Values are represented as the fold change in percentage of peaks overlapping a defined feature over the percent expected by chance give the
genomic base coverage of that feature. Shown to the right is the fraction of total peaks corresponding to each genomic feature for reference. C.
Observed-to-Expected (O/E) ratios of all possible dinucleotides in 5-hmC-enriched regions (n = 82,221, p-value threshold of 1e-8), CpG Islands
(NCBI36/hg18, n = 28,226), and randomly selected genomic regions (n.100,000). D. The cumulative fraction of genomic regions with a given GC
content plotted for 5-hmC-enriched regions (n = 82,221, p-value threshold of 1e-8), CpG Islands (NCBI36/hg18, n = 28,226), and randomly selected
genomic regions (n.100,000).
doi:10.1371/journal.pgen.1002154.g002
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at intergenic CGIs (Figure 2B). Interestingly, we find significantly
more 5-hmC peaks overlapping predicted enhancers than was
expected (8.6-fold over expected, Figure 2B). These results indicate
that in addition to gene body-associated regulatory roles, 5-hmC
may also function within other genomic regions important for gene
modulation.
We also assessed the general sequence content of these peaks,
including GC content and dinucleotide frequencies. We found that
the frequency of CpG dinucleotides within 5-hmC-enriched
regions was no greater than randomly chosen regions of the
genome and significantly lower than CGIs, whereas CA, CC, and
CT dinucleotides each exhibited an O/E .1 and enrichment
relative to random genomic locations (Figure 2C). Furthermore,
GC content as a whole was significantly reduced compared with
CGIs, and slightly increased relative to random genomic loci
(Figure 2D). These data suggest that 5-hmC-enriched loci occur
most often in regions of the genome with moderate GC content
and that it occurs less frequently within a high density of CpGs.
Genome-wide association among 5-hmC, 5-mC, and 11
histone modifications
In order to determine the specific chromatin contexts associated
with 5-hmC in human embryonic stem cells, we obtained sequence
data derived from immunoprecipitation of 5-mC (MeDIP)
(GSM456941) and 11 diverse histone modifications in H1 hES
cells [15]. MeDIP, histone-ChIP, and unenriched input reads
derived from the same experiments were binned genome-wide at 1,
5, and 10 kb. MeDIP and histone-specific signals were normalized
to input values (ChIP-Input). 5-hmC-enriched reads were binned
genome-wide using identical parameters. Input-normalized 5-hmC
signals were then subsequently correlated with input-normalized
histone modification and 5-mC MeDIP values within the same
genomic bin for all bins genome-wide in order to generalize the
relative correlation between 5-hmC, 5-mC, and diverse histone
modifications (Figure 3). We found that data binned at various sized
intervals exhibited generally similar patterns on a genomic scale
when comparing the relative correlations between 5-hmC and the
various histone modifications tested.
We find that in general, on a genomic scale, 5-hmC and 5-mC
detected by MeDIP correlate better than any histone-specific mark
tested (Figure 3A, r2 = 0.448), consistent with the fact that 5-hmC is
derived from 5-mC and with previous reports showing a significant
amount of overlap between the two marks in mouse ES cell
genomes [9,11,13]. Although it is difficult to assess the ratio of 5-
mC:5-hmC from genome-wide bisulfite sequencing data (Methyl
-Seq), we also determined the association between 5-hmC and 5-
Figure 3. Genome-wide correlation among 5-hmC, 5-mC, and 11 distinct histone modifications in human H1 ES cells. (A–L) MeDIP and
ChIP-Seq data for 11 diverse histone modifications and input from the same experiments were obtained from the previous publication and
GSM456941 [15], binned at 10 kb, and normalized to the total number of aligned reads in millions. MeDIP and histone-specific values were then
input-normalized (IP-Input). Data from 5-hmC-enriched and -unenriched input DNA were binned and normalized identically. Input-normalized 5-hmC
signals were then plotted against histone-input normalized values to obtain correlations (r2).
doi:10.1371/journal.pgen.1002154.g003
5-hmC in Human ES Cells
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mC+5-hmC detected by Methyl-Seq (Figure S2). Within the CG
context, regions with higher 5-hmC also tend to have a higher
percentage of 5-mC+5-hmC, as would be expected. However, there
are also a large number of regions with a high percentage of 5-
mC+5-hmC that contain very low levels of 5-hmC and are therefore
presumably dominated by 5-mC (Figure S2A). These results are
again consistent with the notion that 5-hmC is derived from 5-mC.
We also compared 5-hmC signals to 5-mC+5-hmC within the non-
CpG context, which occurs in human ES cells more frequently than
in differentiated cell types [16]. 5-hmC has been reported to occur
within non-CpG contexts in mouse ES cells as well [11]. Our
analyses indicate that regions containing high levels of 5-hmC tend
to harbor less non-CpG methylation (Figure S2B and S2C).
However, due to the low percentage of both CHG and CHH
methylation throughout the genome, it is difficult to resolve the
extent to which 5-hmCmay occur at non-CpG sites and analyses do
not exclude the possibility that 5-hmC occurs within a non-CpG
context in human ES cells. Further resolution of single base pair 5-
hmCwill be required to conclusively establish the sequence contexts
of hydroxymethylated cytosines.
Correlations between 5-hmC and the 11 histone modifications
tested were largely, with a few notable exceptions, in agreement with
the previously observed associations between histone modifications
and the percentage of overall DNA methylation (5-mC+5-hmC)
assessed by Methyl-Seq [15]. Consistent with the correlations
between Methyl-Seq and histone modifications, we find a relatively
strong association between 5-hmC and H3K4me1 (r2= 0.293) and
H3K4me2 (r2=0.152) compared with H3K4me3 (r2=0.0518)
(Figure 3B–3D). The relatively strong correlations between 5-hmC,
H3K4me1, and H3K4me2 compared to H3K4me3 are also
consistent with earlier observations showing enrichment of 5-hmC
within active gene bodies, but depletion at TSSs. We also saw a
relatively strong correlation between H3K18ac, a mark that directly
regulated CBP/p300 enhancer complexes with transcriptional
activation [17,18], and 5-hmC (Figure 3G, r2= 0.324). A significantly
smaller albeit moderate correlation was found between 5-hmC and
H3K27ac, H3K27me3 (with H3K27ac . H3K27me3), and
H4K5ac (Figure 3H, 3I and 3L). Both H3K9ac and H3K9me3
exhibited relatively low levels of correlation with 5-hmC (Figure 3E
and 3F). Surprisingly, we see a relatively weak correlation between 5-
hmC and H3K36me3 (Figure 3J). H3K36me3 is known to correlate
well with gene expression levels and has been linked to transcriptional
elongation in hES cells [19], but is largely absent from TSSs.
H3K36me3 is also one of the few histone marks for which there is a
strong correlation with methylated DNA, as detected by bisulfite
sequencing [15]. These results suggest the possible enrichment of
H3K36me3 or 5-hmC on distinct groups of gene bodies in hES cells,
which could depend on the level of gene expression.
Together, the correlations between 5-hmC, 5-mC, and the 11
specific histone modifications tested indicate that, in addition to
being generally associated with more euchromatic accessible
chromatin, 5-hmC may be linked to diverse gene regulatory
elements and transcriptional regulatory processes in human ES cells.
Expression level–dependent distribution of 5-hmC at
promoter-proximal regions
Both cytogenetic localization of 5-hmC and genome-wide
correlations with 11 diverse histone modifications indicate links
between 5-hmC, more accessible euchromatic chromatin, and
gene regulation. To test the dependence of gene-associated 5-
hmC distributions on expression levels in human ES cells, we
measured 5-hmC signals at genes with varying expression as
measured by RNA-Seq RPKM [16]. Overall, 5-hmC displays a
strong promoter-proximal bias in hES cells, while also being
enriched within gene bodies, albeit to a lesser degree relative to
the TSS (Figure 4A–4E). Interestingly, we observed a distinct
forking in the 5-hmC distribution around the TSS as expression
levels rose, ultimately transitioning to a bimodal distribution at
more highly expressed genes compared with genes expressed at
lower levels (Figure 4A–4E). However, the correlation between
5-hmC and both TSSs and gene bodies is not strictly linear. 5-
hmC tends to be higher, both within the gene body and at the
TSS, at genes expressed within the 25–75% range of all genes
based on RNA-Seq RPKM (Figure 4C and 4D), compared to
the top 25% of expressed genes (Figure 4A). Meanwhile, at
genes within the bottom 25%, 5-hmC is mainly enriched directly
over the TSS and only moderately enriched within the gene
body. Thus, at genes exhibiting lower expression, 5-hmC is
present directly at the TSS (Figure 4E), whereas genes with
intermediate expression display higher gene body 5-hmC and a
distinct bimodal distribution (Figure 4A) at the TSS. At the most
highly expressed genes, 5-hmC exhibits a similar distribution to
that seen on intermediately expressed genes, but overall lower
levels at both the TSS and gene body. These results are
consistent with the observed dual function of 5-hmC in mouse
ES cells, where the Polycomb complex PRC2 may act in
combination with Tet1 to influence the distribution of 5-hmC at
repressed genes, while at more highly expressed genes the
presence of Tet1, without PRC2, results in loss of 5-hmC at the
TSS and establishment of a bimodal distribution [9,10].
To further explore the enrichment of 5-hmC at gene bodies with
intermediate levels of expression, we directly compared the
distribution of 5-hmC to that of H3K36me3 in and around genes
ranked by expression level (Figure 4A). H3K36me3 is an
intragenically enriched histone modification that also correlates well
with gene expression levels [19]. We found that genes with the highest
intragenic 5-hmC also had relatively low intragenic H3K36me3
(Figure 4A), consistent with the relatively low genome-wide
correlations between binned 5-hmC and H3K36me3 (Figure 3J).
The same genes were also those expressed at intermediate levels (25–
75% range based on RNA-Seq RPKM). At the top 25% of expressed
genes, H3K36me3 is highly enriched within gene bodies and
transcription end sites (TES), while 5-hmC tends to be lower at both
TSSs and gene bodies compared to genes expressed at intermediate
levels (Figure 4A). These data suggest a complex relationship between
5-hmC, H3K36me3, and gene expression levels in human ES cells.
One possible explanation could be that 5-hmC functions to temper
transcription at the genes that are not fully committed to a
constitutive expression state. At genes expressed at the lowest levels,
5-hmC may play a role at the TSS to represses full-length
transcription, while still maintaining the transcriptional potential of
the marked genes. Such a role is consistent with the previously
reported interaction between TSS 5-hmC and repression by
Polycomb group complexes, which repress many developmentally
regulated genes in ES cells [9,10]. At the genes with intermediate
expression levels, 5-hmC may temper expression at both TSS and
gene body. At genes with the highest expression, TSS- and gene
body-associated 5-hmC may be, at least in part, replaced by
H3K36me3 to allow full transcriptional potential.
We note that such distributions of 5-hmC in ES cells is distinct
from that observed in mouse brain, where 5-hmC is largely depleted
from TSSs, enriched within gene bodies, and correlates well with
gene expression levels (Szulwach and Jin, unpublished observations
and [14]). These differences may reflect stem cell-specific and brain-
specific roles for 5-hmC-mediated gene regulation. Such differences
may be accounted for by the relative enrichment of Tet1 in ES cells
and/or yet-to-be-identified Tet-family co-factors compared to more
differentiated cell types.
5-hmC in Human ES Cells
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5-hmC differentially marks promoter subtypes in hES cells
In promoter-proximal regions of embryonic stem cells, 5-hmC
exhibits a TSS-associated bias that is dependent on gene
expression level (Figure 4). To further understand the relevance
of this bias in terms of chromatin context, we examined the
distribution of 5-hmC around 18 distinct promoter subtypes
defined on the basis of their chromatin signatures [15]. Among 11
promoter subtypes with significant enrichment of the histone
modifications tested in H1 hES cells, we found that 5-hmC
distributions within the same regions could be classified into two
groups. The first group reflected the distribution of 5-hmC at more
highly expressed genes, with 5-hmC displaying a marked depletion
directly over the TSS and a bimodal distribution around the TSS
(Figure 5A, 5B). This distribution corresponded to a strong
H3K4me3 signal, consistent with an inverse correlation between
5-hmC and H3K4me3 (Figure 5A–5C). Flanking the region of
depletion were two peaks of 5-hmC, which overlapped with
regions of H4K4me1 and H3K4me2 enrichment. A clear example
of this could be seen at the well-characterized promoters of the
DNMT3A locus, itself a highly expressed gene in ES cells
(Figure 5C). The bimodal distribution of 5-hmC, H4K4me1, and
H3K4me2 around TSSs might reflect paused promoters, at which
divergent RNAPII is known to display pausing, and could suggest
an influence of 5-hmC on transcription pausing at such promoters
in hES cells.
The second group of promoters displayed lower 5-hmC signal
overall, but a more even distribution over the promoter regions,
without a distinct region of depletion (Figure 5D–5F), and reflected
the distribution of 5-hmC at genes expressed at intermediate or
low levels (Figure 4). Again, the distribution of 5-hmC correlated
well with the presence of H3K4me1 and H3K4me2, while
H3K4me3 was also present (Figure 5E and 5F). We also noted that
this group of promoters displayed an overall weaker signal in each
histone modification tested, relative to promoters exhibiting
bimodal distributions of both 5-hmC and various histone
modifications (Figure 5B and 5E), which likely represents the
expression status of this group of genes.
Assessment of 5-hmC at an additional seven promoter types,
which displayed low levels of modified histone enrichment in
H1 hES cells, also displayed low levels of 5-hmC (Figure S3) and
less distinct distribution patterns, consistent with a link between
defined histone modifications and 5-hmC at TSSs.
Figure 4. Gene expression level-dependent 5-hmC and H3K36me3 distributions in human ES cells. A. Gene expression values (RPKM)
obtained from [16] were ranked in descending order, and 5-hmC and H3K36me3 read densities were measured in 100-bp bins 65 kb of the TSS or
TES. Values were normalized to the total number of aligned reads in millions. The scale of 5-hmC and H3K36me3 signals are indicated at the below
each respective heatmap. B. 5-hmC and input read densities at the top 25% of genes based on RPKM expression level. C. 5-hmC and input read
densities among genes expressed within the 25–50% range of all genes based on RPKM expression level. D. 5-hmC and input read densities among
genes expressed within the 50–75% range of all genes based on RPKM expression level. E. 5-hmC and input read densities at the bottom 25% of
genes based on RPKM expression level. For B–E, reads were summed in 10-bp windows 2.5 kb upstream and downstream of TSS and TES.
doi:10.1371/journal.pgen.1002154.g004
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Enrichment of 5-hmC at enhancers in hES cells
Association of 5-hmC-enriched regions with annotated genomic
features suggested that, in addition to playing important roles within
gene bodies and gene proximal regions, 5-hmCmight also function at
distinct regulatory elements, including enhancers (Figure 2B). To
address the potential role of 5-hmC at enhancers as well as the
distinct chromatin contexts associated with each, we determined the
distribution of 5-hmC at 12 different sets of predicted enhancers
defined on the basis of chromatin signature [15]. Strikingly, we found
that 5-hmC marked each of five enhancer subtypes displaying
enrichment of H3K4me1, H3K18ac, H4K5ac, and H3K27ac in H1
hES cells, while enhancer subtypes exhibiting less enrichment of these
marks also tended to be less enriched for 5-hmC (Figure 6A and 6B).
A clear example of a 5-hmC-associated enhancer occurred upstream
of the ES-specific gene PRDM14, where a 5-hmC peak was
identified as directly overlapping an E8 type enhancer (Figure 6C).
PRDM14 has been reported as an integral factor contributing to
pluripotency via interactions with the core transcriptional circuitry in
ES cells [20,21]. This may suggest a functional role for 5-hmC, in
combination with at least H3K4me1, at this upstream enhancer in
maintaining expression of PRDM14 and contributing to the
pluripotency of human ES cells. In combination with the general
enrichment of 5-hmC peaks at predicted hES cell enhancers
(Figure 2B), these data demonstrate distinct marking of ES cell
enhancers with 5-hmC and defined chromatin signatures.
5-hmC at defined ChIP-rich regions
We further tested the distribution of 5-hmC around a set of 12
ChIP-rich regions that were previously identified as exhibiting
enrichment of specific histone modifications, but that lay outside of
defined promoters or predicted enhancer regions (Figure S4) [15].
In general, 5-hmC signals were significantly lower at such regions,
Figure 5. 5-hmC marks distinct subtypes of promoters in human H1 ES cells. A. Distribution of 5-hmC at P1-type, bimodal promoters. 5-
hmC reads were summed in 100-bp windows and the immediate 4-kb region, as well as 4 kb upstream and downstream of the immediate 4-kb
region, centered on each H1 hES cell promoter type defined on the basis of their chromatin signature [15,27]. Counts were normalized to the total
number of aligned reads in millions and input reads counted and normalized in the same manner were subtracted. B. Heatmap representations of 5-
hmC and 11 histone modifications at P1-type bimodal promoters. Heatmap scale is indicated below, and maximum values per mark are indicated to
the right of each representative heatmap. C. Genomic view of the DNMT3A locus with read distributions for 5-hmC and 11 histone modifications
exemplifying the bimodal distributions observed. Highlighted in red are the promoter regions. D. Distribution of 5-hmC at P2-type promoters. 5-hmC
reads were summed in 100-bp windows in the immediate 4-kb region, as well as 4 kb upstream and downstream of the immediate 4-kb region,
centered on each H1 hES cell promoter type. Counts were normalized to the total number of aligned reads in millions and input reads counted and
normalized in the same manner were subtracted. E. Heatmap representations of 5-hmC and 11 histone modifications at P2-type bimodal promoters.
Heatmap scale is indicated below, and maximum values per mark are indicated to the right of each representative heatmap. F. Genomic view of the
CENPB locus with read distributions for 5-hmC and 11 histone modifications exemplifying P2-type promoters. Highlighted in red is the promoter
region.
doi:10.1371/journal.pgen.1002154.g005
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and few patterns were apparent. However, we did find that ChIP-
rich regions with H3K36me3 displayed markedly lower levels of 5-
hmC and that regions enriched for K3K9me3 actually exhibited
depletion of 5-hmC (Figure S2), consistent with the lower genome-
wide correlations we found between 5-hmC and these two histone
modifications (Figure 4E and 4I).
5-hmC at pluripotency-associated transcription factor
binding sites
DNA methylation has been implicated in regulating transcrip-
tion factor binding dynamics and has been found to differentially
mark sites of core pluripotency-associated transcription factors in
ES cells [16]. We therefore asked whether or not 5-hmC marked
sites bound by six transcription factors mapped genome-wide in
H1 hES cells, including the pluripotency-associated transcription
factors NANOG, OCT4, and SOX2, as well as more general
factors, such as p300 and TAF1 (Figure 7). At sites of all types we
could detect a slight enrichment of 5-hmC and direct overlap
between subsets of 5-hmC peaks and transcription factor binding
sites, consistent with previous observations in mouse ES cells
detecting 5-hmC at transcription factor binding sites [9,11,13].
However, signals varied across factors. Among pluripotency-
related factors, we find distinct marking and enrichment of 5-hmC
at of only NANOG sites (Figure 7A). An example of 5-hmC
enrichment at a NANOG binding site was seen directly upstream
of DNMT3B (Figure 7B), a gene expressed a high levels in ES
cells. Consistent with a lack of 5-hmC at many TSSs, we also
observe depletion of 5-hmC at TAF1 interaction sites (Figure 7A).
Although we observed good correlation between histone mod-
ifications demarcating enhancers and enrichment of 5-hmC at
specific subtypes of enhancers defined by chromatin signature, we
did not observe distinct 5-hmC marking at p300 sites (Figure 7A).
We further addressed this by asking what the overlap was between
the 82,221 identified 5-hmC enriched regions (Table S1), predicted
enhancers [15] and p300 sites [16]. As expected a large proportion of
p300 sites (1795 of 3094, 58%) overlap predicted enhancers
(Figure 7C). However, the fraction of predicted enhancers explained
by p300 binding remained quite low (1,795 of 58,023, 3.1%),
Figure 6. Enrichment of 5-hmC at specific enhancers in human H1 ES cells. A. 5-hmC reads were summed in 100-bp windows in the
immediate 4-kb region, as well as 4 kb upstream and downstream of the immediate 4-kb region, centered on each of 12 predicted H1 hES cell
enhancers defined on the basis of their chromatin signature [15,27,28]. Counts were normalized to the total number of aligned reads in millions and
input reads counted and normalized in the same manner were subtracted [15,27,28]. B. Heatmap representations of read distributions for 5-hmC and
11 histone modifications at 5 predicted enhancer subtypes found to have significant enrichment in H1 hES cells. Heatmap scale is constant for all
marks and indicated in the lower left-hand corner. C. Genomic view of an E8-type enhancer overlapping a region identified as significantly enriched
for 5-hmC by peak identification upstream of the PRDM14 gene.
doi:10.1371/journal.pgen.1002154.g006
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suggesting a significant amount of enhancer regulation by p300
independent mechanisms. Interestingly, we find that while only a
small fraction of p300 sites (166 of 3094, 5.4%) overlap 5-hmC
enriched regions, a significant percentage of predicted enhancers
(19,973 of 58,023, 34.4%) overlap with 5-hmC enriched regions
(Figure 7C). Furthermore, sites that were enriched for 5-hmC,
bound by p300, and predicted as enhancers were quite rare,
occurring only 25 times. These data suggest that significant portion
of predicted enhancers are also enriched in 5-hmC, but lack p300
binding, and may indicate a role for 5-hmC in regulating p300
independent enhancers.
Together these results indicate that 5-hmC may also influence
the chromatin states at protein-DNA interaction sites, thereby
modulating the function of key transcription factors and diverse
enhancer subtypes.
Discussion
Recent studies have shown that Tet family proteins can catalyze
5-methylcytosince (5-mC) conversion to 5-hydroxymethylcytosine
(5-hmC) and play important roles in self-renewal and cell lineage
specification in embryonic stem (ES) cells [4–6,11,22]. These
findings suggest a potential role for 5-hmC-mediated epigenetic
regulation in modulating the pluripotency of ES cells. To unveil
this new regulatory paradigm in human ES cells, here we used a
selective 5-hmC chemical labeling approach coupled with affinity
purification and deep sequencing that we developed before to
establish the genome-wide distribution of 5-hmC in human ES
cells. Integration of 5-hmC distributions with genome-wide histone
profiles led us to identify the pluripotency-linked chromatin
contexts associated with 5-hmC. Through association with
genomic features defined on the basis of chromatin signatures,
we find 5-hmC-mediated marking of not only specific promoters
and gene bodies, but also distinct enhancer subtypes, including
those marked with H3K4me1 and H3K27Ac. Lastly, we find 5-
hmC is associated with the binding sites of specific core
pluripotency transcription factors and a lack of 5-hmC at others.
Our results suggest that 5-hmC is an important epigenetic
modification associated with the pluripotent state that could play
role(s) in a subset of promoters and enhancers with defined
chromatin signatures in ES cells.
Figure 7. 5-hmC at pluripotency-associated core transcription factor binding sites in human H1 ES cells. A. 5-hmC read distributions at
KLF4 (n = 3,795), OCT4 (n = 3,890), SOX2 (n = 5,684), NANOG (n= 25,076), p300 (n = 3,094), and TAF1 (n = 12,363) binding sites in H1 hES cells. 5-hmC
reads were counted in 40 equally portions within, upstream, and downstream of each binding site and values were normalized to the total number of
aligned reads. Input reads counted and normalized in the same manner were then subtracted. Shown to the right of each plot is a scaled Venn
diagram of the number of transcription factor binding sites (in gray) directly overlapping 5-hmC enriched regions (in black, 82,221) for reference.
Overlaps are defined as $1 bp. B. Genomic view of 5-hmC coverage and 11 histone modifications at the DNMT3B locus, showing overlap of a 5-hmC
peak, NANOG site, and the associated histone modifications. C. Scaled Venn diagram depicting the overlap between 5-hmC enriched regions (black,
82,221), p300 binding sites (gray, 3,094), and predicted enhancers reported in [15] (blue, 58,023). Shown in red is the overlap of all three (25 regions).
Overlaps are defined as $1 bp.
doi:10.1371/journal.pgen.1002154.g007
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By correlating genome-wide distributions of 5-hmC with those
of 11 diverse histone marks, we found that 5-hmC displayed
relatively strong correlations with H3K4me1 and H3K4me2
versus H3K4me3, which, as expected, is consistent with previous
correlations between DNA methylation detected by Methyl-Seq
and histone modifications [15]. 5-hmC also exhibited a strong
correlation with H3K18ac, a mark regulated by CBP/p300 at
enhancers that is associated with transcriptional activation. We
also found more modest correlations with H3K27ac, H3K27me3,
and H4K5ac, and very low correlations with H3K9ac and
H3K9me3. However, our data suggested that 5-hmC was not
strongly correlated with H3K36me3, a histone modification
previously linked to DNA methylation detected by Methyl-Seq.
This intriguing difference suggested differential marking of gene
bodies by 5-hmC and H3K36me3 in pluripotent cells. Direct
comparisons of genic 5-hmC and H3K36me3 indeed revealed that
genes with the highest levels of TSS and gene body 5-hmC tend to
exhibit intermediate levels of expression and harbor less intragenic
H3K36me3, compared to genes with the highest levels of
expression. Although a number of intriguing explanations might
account for these observations, one possibility is that 5-hmC may
function to temper transcription at both the TSS and gene body of
intermediately expressed genes, while maintaining their potential
to be more fully expressed when needed. Upon full activation, 5-
hmC may be at least partially removed as the transcriptional unit
acquires H3K36me3 and commits to a more fully active state.
Restriction of 5-hmC at the TSS of repressed genes and its
presence at both TSSs and gene bodies of intermediately
expressed genes may also indicate distinct regulation of 5-hmC
at these locations. At TSSs of genes that are repressed or expressed
at low levels, Polycomb group complex, PRC2, may interact with
5-hmC to repress but maintain the potential for expression of
targeted genes, as has been previously suggested [9,10]. However,
such distributions are distinct from those observed in mouse
cerebellum [14], where 5-hmC is significantly enriched compared
to ES cells, largely absent from TSSs, and high within gene-bodies,
positively correlating gene-expression. Thus, distinction of me-
chanisms differentially influencing the state and regulation of 5-
hmC within genes bodies in the context of gene expression
outcomes will be important towards understanding the role of 5-
hmC in both brain and ES cells.
Our genome-wide analyses of 5-hmC also revealed a general
promoter-proximal bias of 5-hmC around RefSeq transcripts in
human ES cells, which is consistent with the recently published
work on mapping 5-hmC in mouse ES cells [9,11–13]. This TSS-
associated bias was also dependent on gene expression levels, with
5-hmC transitioning from a position directly over the TSS at
repressed genes to a bimodal distribution at more highly expressed
genes, likely reflecting the observed dual function of 5-hmC in
mouse ES cells [9–13], although this correlation was not strictly
linear. Interestingly, we find that the bimodal distribution of 5-
hmC is also strongly correlated with the distributions of H3K4me1
and H3K4me2, but inversely correlated with H3K4me3. The
bimodal distribution of 5-hmC, H4K4me1, and H3K4me2
around TSSs might reflect the establishment of divergent paused
RNAPII, which is known to play a critical regulatory role at
developmentally regulated transcripts in ES cells [23,24]. This
could thereby point to an influence of 5-hmC on transcription
pausing at such promoters in hES cells. We also noted that such a
promoter-proximal bias of 5-hmC in ES cells is distinct from that
observed in mouse brain, where 5-hmC is largely depleted from
TSSs and enriched within gene bodies (Szulwach and Jin,
unpublished observations and [14]), where it also correlates well
with gene expression. This could suggest that such a bias reflects a
stem cell-specific role for 5-hmC-mediated gene regulation at and
around certain TSSs. Such differences may be accounted for by
the enrichment of Tet1, or yet-to-be-identified co-factors of Tet1,
in ES cells relative to more differentiated cell types.
Analyses of 5-hmC-enriched peaks and their correlation with
enhancer-associated specific histone modifications, such as
H3K4me1, H3K18ac, and H3K27ac, suggested that, in addition
to being present at promoters, 5-hmC could also mark other
diverse regulatory elements in the genome, such as enhancers.
Interestingly, assessment of 5-hmC distributions at the predicted
enhancers in H1 hES cells demonstrated the enrichment of the
epigenetic mark at specific enhancer subtypes, including those
enriched for K3K4me1, H3K27ac, H3K18ac, and H4K5ac.
Despite a good correlation between 5-hmC and histone marks
demarcating enhancers, we found that only small fraction of
regions bound by p300 were also enriched for 5-hmC.
Finally, we examined the correlation of 5-hmC distributions
with the genome-wide binding sites of six transcription factors that
have been linked to maintaining the pluripotency of ES cells [16].
We find that 5-hmC can also mark NANOG binding sites, while
being depleted at TAF1 sites. These results further suggest diverse
roles for 5-hmC in regulating the accessibility of transcription
factors in defined chromatin contexts, including those regulating
pluripotency in ES cells.
In summary, here we present the genome-wide distribution of 5-
hmC and its correlation with 11 diverse histone modifications and
six transcription factors in human ES cells. By integrating genomic
5-hmC signals with maps of different histone marks, we link
particular pluripotency-associated chromatin contexts with 5-
hmC. Our study suggests that 5-hmC could play diverse roles in
regulating specific promoters, gene bodies, and enhancers in ES
cells, thereby providing a detailed epigenomic map of 5-hmC from
which to study its contribution to pluripotency.
Materials and Methods
Human ES cell culture
H1 human ES cells were maintained on mitomycin C-treated
STO cells in ES medium consisting of DMEM/F12 medium
(Invitrogen) supplemented with 20% serum replacement (SR;
Invitrogen), 1 mM L-glutamine (Invitrogen), 100 mM nonessential
amino acids (Invitrogen), 0.1 mM ß-mercaptoethanol (Sigma), 1X
Antibiotics-Antimycotic (Invitrogen), and 4 ng/mL bFGF (Invi-
trogen). The fully grown H1 cells were mechanically isolated and
transferred into a prepared dish with fresh feeder cells. Prior to the
isolation of genomic DNA, cells were treated with dispase (2 mg/
ml in DMEM/F12) to detach human ES cells from feeder cells.
Metaphase chromosome preparation and staining
Metaphase chromosomes were prepared by standard protocols
as described previously [25]. The slides with hES metaphase
chromosome spreads were washed with PBS for 5 min. The slides
were immersed in 1N HCl and incubated at 37uC for 30 min.
After HCl treatment, the slides were washed with PBS for 15 min
followed by blocking with 3% goat serum/0.4 Triton X-100 in
PBS for 1 h. The samples were incubated with primary antibodies
at 4uC overnight. The following primary antibodies were used:
rabbit anti 5-hydroxymehtylcytosine (1:10,000, #39769, Active
Motif), mouse anti-5-methylcytosine (1:1000, Eurogentec, BI-
MECY-0100). On the second day, the slides were washed with
PBS and then incubated with secondary antibodies: goat anti-
rabbit Alexa488 (1:500, #A11008, Invitrogen) and goat anti-
mouse Alexa568 (1:500, #A11031, Invitrogen). The slides were
counter-stained with the fluorescent nuclear dye 49,6-diamidino-2-
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phenylindole (#B2261, Sigma). The slides were examined using a
Zeiss AX10 microscope, and images were processed with Photo-
shop software. More than 5 metaphase spreads were examined for
5-mC and 5-hmC.
Genomic DNA preparation
Genomic DNA was isolated by cell lysis in digestion buffer
(100 mM Tris-HCl, pH 8.5, 5 mM EDTA, 0.2% SDS, 200 mM
NaCl), Proteinase K treatment (0.667 ug/ul, 55uC overnight). The
second day, an equal volume of Phenol:Chloroform:Isoamyl
Alcohol (25:24:1 Saturated with 10 mM Tris, pH 8.0, 1 mM
EDTA) (P-3803, Sigma) was added to samples, mixed completely,
and centrifuged for 5 min at 14,000 rpm. The aqueous layer
solution was transferred into a new Eppendorf tube and
precipitated with 2 volumes 100% ethanol and 1/10 volume
3 M NaOAc. The genomic DNA was recovered and dissolved
with 10 mM Tris-HCl, pH 8.0. Genomic DNA samples were
further sonicated into ,500 bp by Misonix sonicator 3000 (using
microtip, 4 pulses of 27 s each, with 1 min of rest and a power
output level of 2; the sonication was performed always on ice). The
fragment size of sonicated DNA was verified by agarose gel
electrophoresis. The DNA concentration was determined with
NANO-DROP 1000 (Thermo Scientific).
5-hmC and 5-mC dot blot
The dot blot was performed on a Bio-Dot Apparatus (#170-
6545, BIO-RAD). Briefly, the serially diluted C, 5-mC, or 5-
hmC only standard DNA samples (Zymo research) were mixed
with 2N NaOH and 10 mM Tris?Cl, pH 8.5, and loaded onto
6X SSC rinsed Hybond-N+ membrane (Amersham Biosciences,
#RPN303B). The completely dried membrane was baked for
30 min at 80uC and then blocked with PBS containing 5% dry
milk and 0.1% Triton X-100 for 1 h at room temperature.
The primary rabbit anti-5-hydroxymethylcytosine antibody
(1:10,000, #39769, Active Motif) or (1:1,000, mouse mono-
clonal anti-5-methylcytosine, BI-MECY-0100, Anaspec) was
applied to the membrane and incubated overnight at 4uC. The
second day, the membrane was rinsed with PBS and the signal
was developed after incubation with HRP-conjugated secondary
antibody for 30 min.
5-hmC–specific chemical labeling and affinity purification
5-hmC enrichment was performed using a previously described
procedure with an improved selective chemical labelling method
[14]. Briefly, the 5-hmC labelling reactions were performed in a
100-mL solution containing 50 mM HEPES buffer (pH 7.9),
25 mM MgCl2, 300 ng/mL sonicated genomic DNA (100–
500 bp), 250 mM UDP-6-N3-Glu, and 2.25 mM wild-type b-GT.
The reactions were incubated for 1 h at 37uC. After the reaction,
the DNA substrates were purified via Qiagen DNA purification kit
or by phenol-chloroform precipitation and reconstituted in H2O.
The click chemistry was performed with the addition of 150 mM
dibenzocyclooctyne-modified biotin into the DNA solution, and
the reaction mixture was incubated for 2 h at 37uC. The DNA
samples were then purified by Pierce Monomeric Avidin Kit
(Thermo) following the manufacturer’s recommendations. After
elution, the biotin-5-N3-gmC-containing DNA was concentrated
by 10 K Amicon Ultra-0.5 mL Centrifugal Filters (Millipore) and
purified by Qiagen DNA purification kit.
Sequencing of 5-hmC–enriched and input genomic DNA
DNA libraries were generated following the Illumina protocol
for ‘‘Preparing Samples for ChIP Sequencing of DNA’’ (Part#
111257047 Rev. A). We used 25 ng of input genomic DNA or 5-
hmC-captured DNA to initiate the protocol. DNA fragments of
,150–300 bp were gel-purified after the adapter ligation step.
PCR-amplified DNA libraries were quantified on an Agilent 2100
Bioanalyzer and diluted to 6-8 pM for cluster generation and
sequencing. We performed 38-cycle single-end sequencing using
Version 4 Cluster Generation and Sequencing Kits (Part
#15002739 and#15005236 respectively) and Version 7.0 recipes.
Image processing and sequence extraction were done using the
standard Illumina Pipeline.
Sequence alignment, binning, and peak identification
FASTQ sequence files were aligned to the Human reference
(NCBI36, hg18) using Bowtie 0.12.6, retaining only unique, non-
duplicate genomic matches with no more than 2 mismatches
within the first 25 bp.
Unique, non-duplicate reads from non-enriched input genomic
DNA and each 5-hmC-enriched sequence set were counted in
1000-, 5000-, and 10,000-bp bins genome-wide and subsequently
normalized to the total number of non-duplicate reads in millions.
We find that bins of varying size produce largely similar patterns
genome wide and have reported values within a bin size of 10 kb
within all figures. Input-normalized values were subtracted from 5-
hmC-enriched values per bin to generate normalized 5-hmC
signals.
Summary of sequence output: H1, 5-hmC enriched =10038770
non-duplicate reads, H1, Unenriched input =20656172 non-
duplicate reads.
Chromosome-wide densities were determined as reads per
chromosome divided by the total number of reads in millions.
Expected values were determined by dividing 106 by the total
NCBI36/hg18 length, and multiplying by chromosomal length.
Expected values were divided by 2 for chromosomes X and Y.
For MeDIP/histone modification correlations, unique, non-
duplicate reads from non-enriched input genomic DNA and 5-
hmC-enriched DNA were counted in 10,000-bp bins genome-
wide and subsequently normalized to the total number of non-
duplicate reads in millions. Input-normalized values were
subtracted from 5-hmC/histone-enriched values per bin to
generate normalized 5-hmC/histone signals. All histone ChIP-
Seq data was acquired from Sequence Read Archive (SRA),
accession SRP000941, [15]. MeDIP data were obtained from
NCBI GEO Accession GSM456941. All histone ChIP-Seq data
and MeDIP were mapped and processed with the identical
parameters used for 5-hmC reads described above.
5-hmC peaks were identified using MACS [26] with the
following parameters: effective genome size = 2.7e+09; Tag size
= 38; Bandwidth = 200; P-value cutoff = 1.00e-08; ranges for
calculating regional lambda are: peak_region, 200, 1000.
Association of 5-hmC peaks with genomic features was
performed by overlapping peak locations with known genomic
features obtained from UCSC Tables for NCBI36/hg18: RefSeq
Whole Gene, 59UTR, Exon, Intron, 39UTR, +/2500 bp of
RefSeq TSS, RefSeq Intergenic (complement of Whole Gene),
CpG Islands (+/22 kb of CGI, Intergenic/Intragenic/TSS based
on RefSeq Whole Gene). Predicted enhancer locations were
obtained from [15]. Peaks were assigned to a given genomic
feature if overlapping $1 bp. Expected values were determined
based on the percent base coverage of each defined genomic
feature in NCBI36/hg18.
Histone ChIP-Seq and chromatin signatures
All histone ChIP-Seq data were acquired from Sequence Read
Archive (SRA), accession SRP000941. All histone ChIP-Seq data
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were mapped and processed with the identical parameters used for
5-hmC reads described above. Chromatin signatures for promo-
ters, enhancers, and ChIP-rich regions were acquired from [15].
5-hmC reads were counted in 100-bp bins, in the 4 kb directly
surrounding identified binding sites, as well as 4 kb upstream and
downstream of the immediate 4-kb region. Read counts were
normalized to the total number of aligned reads in millions and
input reads counted and normalized in the same manner were
subsequently subtracted to determine 5-hmC enrichment.
Pluripotency-associated transcription factor binding sites
and H1 hES RNA-Seq
RNA-Seq RPKM values and transcription factor binding sites
for KLF4, NANOG, OCT4, p300, SOX2, and TAF1 in H1 ES
cells were described previously [16]. For correlations between 5-
hmC and gene expression, 5-hmC reads were counted in 100-bp
bins, in the 65 kb directly surrounding TSSs and TESs. Read
counts were normalized to the total number of aligned reads in
millions. For transcription factor binding sites, 5-hmC reads were
counted in 40 equally sized portions within, upstream, and
downstream of the binding sites. Read counts were normalized to
the total number of aligned reads in millions and input reads
counted and normalized in the same manner were subtracted to
determine 5-hmC enrichment.
Methyl-seq data and analysis
Methyl cytosine counts in the CG, CHG, or CHH context were
obtained directly from [16] and the percent methylation in each
10 kb bin genome-wide was determined as the weighted sum of
methylated cytosine detected at each position.
Supporting Information
Figure S1 Verification of 5-mC and 5-hmC antibody specificity.
Dot blots of cytosine only (C), 5-methylcytosine only (mC), or 5-
hydroxymethylcytosine only (5-hmC), control DNA (949 bp,
Zymo Research) demonstrating the specificity of anti-5 mC and
anti-5-hmC antibodies used on metaphase spreads.
(TIF)
Figure S2 Correlation between 5-hmC and methyl-seq CG,
CHG, and CGG DNA methylation. A. 5-hmC versus percent 5-
mCG detected by methyl-seq. B. 5-hmC versus percent 5-mCHG
detected by methyl-seq. C. 5-hmC versus percent 5-mCHH
detected by methyl-seq. For all plots 5-hmC and input reads were
counted in 10 kb bins, normalized to the total number of aligned
reads in millions and input values were subtracted from 5-hmC
values. Methyl cytosine counts in the CG, CHG, or CHH context
were obtained directly from [16] and the percent methylation in
each 10 kb bin genome-wide was determined as the weighted sum
of methylated cytosine detected at each position.
(TIF)
Figure S3 Distribution of 5-hmC at P12–P18 type promoters
previously defined on the basis of their chromatin signature
[15,27]. 5-hmC reads were summed in 100-bp windows and the
immediate 4 kb region, as well as 4 kb upstream and downstream
of the immediate 4 kb region, centered on each H1 hES cell
promoter type. Read counts were normalized to the total number
of read in millions and input reads counted and normalized in the
same manner were subtracted.
(TIF)
Figure S4 Distribution of 5-hmC at 12 ChIP-rich regions
previously defined on the basis of their chromatin signature that lie
outside known promoters and predicted enhancers [15,27]. 5-
hmC reads were summed in 100-bp windows and the immediate
4 kb region, as well as 4 kb upstream and downstream of the
immediate 4 kb region, centered on each H1 hES cell promoter
type. Read counts were normalized to the total number of read in
millions and input reads counted and normalized in the same
manner were subtracted. Histone marks identified as enriched at
particular ChIP-rich regions are indicated to the right of the
specific regions.
(TIF)
Table S1 List of 82,221 5-hmC enriched regions in H1 hES
cells.
(XLSX)
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